| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 81 | 2024 | 3638 | 6.300 |
Why?
|
| Mass Spectrometry | 58 | 2024 | 2204 | 4.520 |
Why?
|
| Proteome | 37 | 2023 | 1798 | 3.270 |
Why?
|
| Proteins | 34 | 2023 | 6100 | 2.110 |
Why?
|
| Tandem Mass Spectrometry | 25 | 2018 | 1157 | 2.040 |
Why?
|
| Chromatography, Liquid | 26 | 2022 | 976 | 1.970 |
Why?
|
| Pancreatitis, Chronic | 11 | 2022 | 285 | 1.680 |
Why?
|
| Pancreatic Juice | 8 | 2021 | 62 | 1.520 |
Why?
|
| Peptides | 19 | 2024 | 4410 | 1.410 |
Why?
|
| Polyvinyls | 3 | 2021 | 157 | 1.380 |
Why?
|
| Pancreatic Stellate Cells | 4 | 2013 | 28 | 1.360 |
Why?
|
| Body Fluids | 5 | 2024 | 319 | 1.310 |
Why?
|
| Phosphopeptides | 6 | 2017 | 241 | 1.060 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2022 | 745 | 1.020 |
Why?
|
| Pancreatic Function Tests | 8 | 2021 | 69 | 0.950 |
Why?
|
| Protein Processing, Post-Translational | 16 | 2024 | 1988 | 0.950 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 10 | 2011 | 504 | 0.900 |
Why?
|
| High-Throughput Screening Assays | 3 | 2017 | 944 | 0.880 |
Why?
|
| Phosphotyrosine | 6 | 2003 | 457 | 0.840 |
Why?
|
| Sequence Analysis, Protein | 10 | 2013 | 258 | 0.810 |
Why?
|
| Cell Fractionation | 2 | 2015 | 252 | 0.800 |
Why?
|
| Herpesviridae Infections | 1 | 2022 | 277 | 0.770 |
Why?
|
| Meningitis | 1 | 2022 | 216 | 0.770 |
Why?
|
| Specimen Handling | 5 | 2021 | 694 | 0.740 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 11 | 2013 | 1801 | 0.730 |
Why?
|
| HeLa Cells | 21 | 2020 | 3130 | 0.730 |
Why?
|
| Subcellular Fractions | 5 | 2015 | 547 | 0.730 |
Why?
|
| Pancreas | 5 | 2013 | 1687 | 0.720 |
Why?
|
| Acute-Phase Proteins | 1 | 2020 | 262 | 0.690 |
Why?
|
| Ebolavirus | 1 | 2022 | 263 | 0.680 |
Why?
|
| Encephalitis | 1 | 2022 | 425 | 0.670 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2011 | 362 | 0.670 |
Why?
|
| Blood Proteins | 3 | 2022 | 1124 | 0.660 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 306 | 0.630 |
Why?
|
| Software | 7 | 2020 | 4442 | 0.630 |
Why?
|
| Ovarian Cysts | 2 | 2015 | 115 | 0.630 |
Why?
|
| Phosphorylation | 29 | 2023 | 8437 | 0.610 |
Why?
|
| Pancreatectomy | 2 | 2022 | 804 | 0.600 |
Why?
|
| Complement System Proteins | 1 | 2020 | 795 | 0.590 |
Why?
|
| Immunoglobulins | 1 | 2020 | 881 | 0.590 |
Why?
|
| Herpesvirus 1, Human | 1 | 2022 | 743 | 0.590 |
Why?
|
| Membranes | 1 | 2017 | 173 | 0.570 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2022 | 428 | 0.570 |
Why?
|
| Endoscopy, Digestive System | 7 | 2021 | 345 | 0.510 |
Why?
|
| Trypsin | 5 | 2012 | 511 | 0.510 |
Why?
|
| Immune System | 1 | 2020 | 806 | 0.510 |
Why?
|
| Tyrosine | 8 | 2009 | 1462 | 0.500 |
Why?
|
| Computational Biology | 11 | 2019 | 3519 | 0.490 |
Why?
|
| Urine | 4 | 2013 | 370 | 0.480 |
Why?
|
| Isotope Labeling | 9 | 2012 | 406 | 0.460 |
Why?
|
| Amphibian Proteins | 1 | 2013 | 36 | 0.460 |
Why?
|
| Amino Acid Sequence | 25 | 2014 | 13814 | 0.450 |
Why?
|
| Zygote | 1 | 2013 | 116 | 0.440 |
Why?
|
| Membrane Microdomains | 3 | 2009 | 203 | 0.440 |
Why?
|
| Filarioidea | 1 | 2012 | 9 | 0.430 |
Why?
|
| Synovial Fluid | 1 | 2014 | 394 | 0.420 |
Why?
|
| Hepatic Stellate Cells | 1 | 2013 | 109 | 0.420 |
Why?
|
| Child Development | 2 | 2020 | 2223 | 0.410 |
Why?
|
| Phosphoproteins | 8 | 2020 | 2441 | 0.400 |
Why?
|
| Embryo, Nonmammalian | 3 | 2013 | 895 | 0.390 |
Why?
|
| Pancreatic Ducts | 1 | 2013 | 328 | 0.380 |
Why?
|
| Organelles | 1 | 2013 | 264 | 0.380 |
Why?
|
| Molecular Sequence Data | 23 | 2014 | 18111 | 0.380 |
Why?
|
| Data Mining | 1 | 2015 | 537 | 0.370 |
Why?
|
| Tryptophan | 3 | 2002 | 478 | 0.360 |
Why?
|
| Chickens | 1 | 2012 | 865 | 0.360 |
Why?
|
| Programming Languages | 1 | 2010 | 133 | 0.350 |
Why?
|
| Abdominal Pain | 2 | 2015 | 1064 | 0.350 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 788 | 0.340 |
Why?
|
| Software Design | 1 | 2009 | 176 | 0.340 |
Why?
|
| Humans | 122 | 2024 | 744376 | 0.340 |
Why?
|
| Pancreatic Diseases | 3 | 2021 | 350 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2020 | 2962 | 0.340 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2005 | 277 | 0.340 |
Why?
|
| Nucleic Acids | 2 | 2021 | 182 | 0.330 |
Why?
|
| Staining and Labeling | 1 | 2013 | 1101 | 0.330 |
Why?
|
| Peptide Fragments | 7 | 2012 | 5096 | 0.320 |
Why?
|
| Cell Line | 20 | 2017 | 16000 | 0.320 |
Why?
|
| Urinalysis | 2 | 2010 | 369 | 0.320 |
Why?
|
| Nicotine | 1 | 2013 | 681 | 0.320 |
Why?
|
| tau Proteins | 4 | 2024 | 1868 | 0.310 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 8038 | 0.310 |
Why?
|
| Peptide Mapping | 4 | 2012 | 263 | 0.310 |
Why?
|
| Databases, Protein | 5 | 2017 | 383 | 0.300 |
Why?
|
| Strongyloides ratti | 3 | 2011 | 3 | 0.300 |
Why?
|
| Ribosomal Proteins | 4 | 2015 | 360 | 0.300 |
Why?
|
| Duodenum | 1 | 2010 | 484 | 0.300 |
Why?
|
| Choroid Plexus | 2 | 2023 | 231 | 0.290 |
Why?
|
| Chemical Precipitation | 3 | 2013 | 179 | 0.290 |
Why?
|
| Pancreatitis | 4 | 2018 | 1092 | 0.280 |
Why?
|
| Mycobacterium tuberculosis | 5 | 2021 | 1832 | 0.280 |
Why?
|
| DNA | 9 | 2012 | 7294 | 0.280 |
Why?
|
| Workflow | 4 | 2021 | 847 | 0.280 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 824 | 0.270 |
Why?
|
| Algorithms | 11 | 2020 | 13882 | 0.270 |
Why?
|
| Sulfotransferases | 1 | 2006 | 151 | 0.270 |
Why?
|
| Hydroxyproline | 2 | 2019 | 116 | 0.270 |
Why?
|
| Knee Joint | 1 | 2014 | 1680 | 0.260 |
Why?
|
| Glycoproteins | 5 | 2013 | 2266 | 0.260 |
Why?
|
| Proteinuria | 1 | 2008 | 658 | 0.260 |
Why?
|
| Transplantation, Autologous | 2 | 2022 | 2124 | 0.260 |
Why?
|
| Central Nervous System | 2 | 2022 | 1357 | 0.250 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2005 | 49 | 0.250 |
Why?
|
| Selection, Genetic | 1 | 2010 | 914 | 0.250 |
Why?
|
| Animals | 52 | 2024 | 168770 | 0.250 |
Why?
|
| Sarcosine | 1 | 2024 | 16 | 0.240 |
Why?
|
| Molecular Weight | 5 | 2013 | 2255 | 0.230 |
Why?
|
| Cerebrospinal Fluid | 3 | 2015 | 535 | 0.230 |
Why?
|
| Membrane Proteins | 5 | 2015 | 7882 | 0.230 |
Why?
|
| Onium Compounds | 1 | 2003 | 31 | 0.230 |
Why?
|
| Bacterial Proteins | 4 | 2021 | 3854 | 0.220 |
Why?
|
| Microfilament Proteins | 4 | 2015 | 1152 | 0.220 |
Why?
|
| Signal Transduction | 18 | 2020 | 23406 | 0.220 |
Why?
|
| Imines | 1 | 2002 | 33 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2012 | 1572 | 0.220 |
Why?
|
| West Nile virus | 1 | 2022 | 82 | 0.210 |
Why?
|
| West Nile Fever | 1 | 2022 | 81 | 0.210 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2022 | 32 | 0.210 |
Why?
|
| Cross-Linking Reagents | 2 | 2002 | 694 | 0.210 |
Why?
|
| Databases, Factual | 4 | 2010 | 7730 | 0.210 |
Why?
|
| Dihematoporphyrin Ether | 2 | 2000 | 31 | 0.200 |
Why?
|
| Archives | 1 | 2021 | 16 | 0.200 |
Why?
|
| Zebrafish Proteins | 1 | 2008 | 1005 | 0.200 |
Why?
|
| Herpesvirus 3, Human | 1 | 2022 | 204 | 0.200 |
Why?
|
| Histone Demethylases | 2 | 2015 | 321 | 0.200 |
Why?
|
| Serpins | 1 | 2023 | 247 | 0.200 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2373 | 0.200 |
Why?
|
| Herpesvirus 2, Human | 1 | 2022 | 189 | 0.200 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2003 | 434 | 0.190 |
Why?
|
| Helminth Proteins | 2 | 2011 | 171 | 0.190 |
Why?
|
| Acyltransferases | 2 | 2020 | 294 | 0.180 |
Why?
|
| Dactinomycin | 3 | 2002 | 318 | 0.180 |
Why?
|
| HIV Infections | 3 | 2022 | 16715 | 0.180 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 139 | 0.180 |
Why?
|
| Porphyrins | 4 | 2000 | 348 | 0.180 |
Why?
|
| Ethanol | 3 | 2018 | 1342 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 12073 | 0.180 |
Why?
|
| Cytokines | 5 | 2022 | 7323 | 0.180 |
Why?
|
| Actinin | 1 | 2020 | 160 | 0.170 |
Why?
|
| BCG Vaccine | 1 | 2022 | 369 | 0.170 |
Why?
|
| Chromatography, Affinity | 3 | 2014 | 549 | 0.170 |
Why?
|
| Xenopus laevis | 3 | 2013 | 957 | 0.170 |
Why?
|
| Tauopathies | 1 | 2023 | 307 | 0.170 |
Why?
|
| Reproducibility of Results | 13 | 2015 | 19905 | 0.170 |
Why?
|
| Preservation, Biological | 1 | 2018 | 25 | 0.170 |
Why?
|
| Gap Junctions | 1 | 2000 | 233 | 0.170 |
Why?
|
| Actins | 4 | 2020 | 2121 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 3 | 2022 | 1000 | 0.170 |
Why?
|
| Infant, Newborn | 6 | 2022 | 25628 | 0.160 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 345 | 0.160 |
Why?
|
| Protein Array Analysis | 2 | 2011 | 411 | 0.160 |
Why?
|
| Radiation-Sensitizing Agents | 3 | 2000 | 358 | 0.160 |
Why?
|
| ROC Curve | 3 | 2023 | 3527 | 0.160 |
Why?
|
| Reference Standards | 2 | 2012 | 1025 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 329 | 0.150 |
Why?
|
| Cysteine | 2 | 2009 | 873 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2009 | 168 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2013 | 2969 | 0.150 |
Why?
|
| Cell Cycle | 4 | 2014 | 2968 | 0.150 |
Why?
|
| Peptide Library | 2 | 2015 | 349 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2013 | 1085 | 0.150 |
Why?
|
| Immunoassay | 2 | 2011 | 752 | 0.150 |
Why?
|
| Transposases | 1 | 2017 | 107 | 0.150 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2020 | 357 | 0.140 |
Why?
|
| Lyme Disease | 1 | 2022 | 621 | 0.140 |
Why?
|
| Megakaryocytes | 2 | 2012 | 545 | 0.140 |
Why?
|
| Cloning, Molecular | 4 | 2012 | 4320 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 820 | 0.140 |
Why?
|
| Wilms Tumor | 1 | 2019 | 373 | 0.140 |
Why?
|
| Hydrocephalus | 1 | 2023 | 748 | 0.140 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 229 | 0.140 |
Why?
|
| Podocytes | 1 | 2020 | 396 | 0.140 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 971 | 0.140 |
Why?
|
| Models, Biological | 5 | 2014 | 9584 | 0.140 |
Why?
|
| Albuminuria | 1 | 2020 | 681 | 0.140 |
Why?
|
| Mice | 19 | 2023 | 81202 | 0.140 |
Why?
|
| Photosensitizing Agents | 1 | 2000 | 602 | 0.140 |
Why?
|
| Bayes Theorem | 3 | 2013 | 2308 | 0.140 |
Why?
|
| Rats | 9 | 2017 | 24252 | 0.140 |
Why?
|
| Sensitivity and Specificity | 7 | 2015 | 14723 | 0.140 |
Why?
|
| Cadherins | 2 | 2013 | 907 | 0.130 |
Why?
|
| Linear Models | 2 | 2020 | 5952 | 0.130 |
Why?
|
| Protein Isoforms | 6 | 2020 | 1730 | 0.130 |
Why?
|
| Neural Tube | 1 | 2015 | 46 | 0.130 |
Why?
|
| Cystitis, Interstitial | 2 | 2012 | 61 | 0.130 |
Why?
|
| Adsorption | 1 | 2015 | 201 | 0.130 |
Why?
|
| Fourth Ventricle | 1 | 2015 | 30 | 0.130 |
Why?
|
| Cell Extracts | 1 | 2015 | 138 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
| Tubulin | 3 | 2013 | 695 | 0.130 |
Why?
|
| Escherichia coli | 3 | 2001 | 4217 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2005 | 1888 | 0.130 |
Why?
|
| Photochemotherapy | 2 | 2000 | 807 | 0.130 |
Why?
|
| Apoptosis | 4 | 2020 | 9726 | 0.130 |
Why?
|
| Photochemistry | 3 | 2002 | 238 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 1081 | 0.130 |
Why?
|
| Hypersensitivity | 1 | 2024 | 1102 | 0.120 |
Why?
|
| Ubiquitination | 3 | 2014 | 1012 | 0.120 |
Why?
|
| Freezing | 2 | 2021 | 303 | 0.120 |
Why?
|
| Protein Stability | 2 | 2021 | 556 | 0.120 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 299 | 0.120 |
Why?
|
| Tissue Fixation | 2 | 2013 | 241 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 296 | 0.120 |
Why?
|
| Phenothiazines | 1 | 2014 | 63 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3773 | 0.120 |
Why?
|
| Lateral Ventricles | 1 | 2015 | 147 | 0.120 |
Why?
|
| Appendicitis | 2 | 2012 | 645 | 0.120 |
Why?
|
| Lipoylation | 2 | 2011 | 72 | 0.120 |
Why?
|
| Cell Communication | 2 | 2000 | 1621 | 0.120 |
Why?
|
| Formaldehyde | 2 | 2013 | 353 | 0.120 |
Why?
|
| Dynamin II | 1 | 2013 | 35 | 0.120 |
Why?
|
| Protozoan Proteins | 1 | 2020 | 827 | 0.120 |
Why?
|
| Female | 34 | 2024 | 380200 | 0.120 |
Why?
|
| Gene Expression | 4 | 2021 | 7798 | 0.120 |
Why?
|
| Membranes, Artificial | 1 | 2015 | 378 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 13035 | 0.120 |
Why?
|
| Substrate Specificity | 3 | 2014 | 1802 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 370 | 0.120 |
Why?
|
| Collagen Type VI | 1 | 2013 | 26 | 0.110 |
Why?
|
| Cells, Cultured | 10 | 2020 | 19233 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2013 | 9647 | 0.110 |
Why?
|
| Urinary Bladder | 3 | 2016 | 1173 | 0.110 |
Why?
|
| Nucleosides | 1 | 1994 | 138 | 0.110 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 711 | 0.110 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 390 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 823 | 0.110 |
Why?
|
| Xenopus | 2 | 2012 | 712 | 0.110 |
Why?
|
| Gestational Age | 1 | 2022 | 3493 | 0.110 |
Why?
|
| Ions | 3 | 2003 | 265 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 280 | 0.110 |
Why?
|
| Centrifugation | 1 | 2013 | 122 | 0.110 |
Why?
|
| Cell Differentiation | 5 | 2015 | 11486 | 0.110 |
Why?
|
| Detergents | 2 | 2015 | 230 | 0.110 |
Why?
|
| Cytosol | 2 | 2013 | 901 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2012 | 783 | 0.110 |
Why?
|
| Statistics, Nonparametric | 3 | 2013 | 2887 | 0.110 |
Why?
|
| Filtration | 1 | 2013 | 234 | 0.110 |
Why?
|
| Guanine | 1 | 1994 | 274 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1771 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2021 | 1122 | 0.110 |
Why?
|
| Antioxidants | 1 | 2020 | 1659 | 0.110 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2012 | 22 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2010 | 1520 | 0.110 |
Why?
|
| Metalloproteases | 1 | 2012 | 62 | 0.110 |
Why?
|
| Swine, Miniature | 1 | 2014 | 961 | 0.110 |
Why?
|
| Male | 29 | 2022 | 350118 | 0.100 |
Why?
|
| Neurons | 4 | 2015 | 9340 | 0.100 |
Why?
|
| Fixatives | 1 | 2012 | 94 | 0.100 |
Why?
|
| Tuberculosis | 2 | 2022 | 1912 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2022 | 8319 | 0.100 |
Why?
|
| Infant | 9 | 2022 | 35134 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 229 | 0.100 |
Why?
|
| Heat-Shock Proteins, Small | 1 | 2011 | 5 | 0.100 |
Why?
|
| Child | 12 | 2022 | 77708 | 0.100 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 494 | 0.100 |
Why?
|
| Kidney | 4 | 2019 | 7184 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2015 | 688 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 160 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1405 | 0.100 |
Why?
|
| Antitubercular Agents | 1 | 2020 | 1320 | 0.100 |
Why?
|
| Perilymph | 1 | 2011 | 49 | 0.100 |
Why?
|
| Extracellular Fluid | 1 | 2013 | 167 | 0.100 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2012 | 61 | 0.100 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2011 | 89 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 2752 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2012 | 234 | 0.100 |
Why?
|
| Myositis, Inclusion Body | 1 | 2013 | 147 | 0.100 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5857 | 0.100 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2011 | 96 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 1741 | 0.100 |
Why?
|
| RNA Interference | 5 | 2020 | 2891 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 453 | 0.100 |
Why?
|
| Zinc | 1 | 2015 | 684 | 0.100 |
Why?
|
| Flow Cytometry | 8 | 2000 | 5974 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2011 | 1892 | 0.090 |
Why?
|
| Acetone | 1 | 2010 | 43 | 0.090 |
Why?
|
| DNA Polymerase II | 1 | 1991 | 107 | 0.090 |
Why?
|
| 14-3-3 Proteins | 1 | 2011 | 214 | 0.090 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2010 | 30 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 2 | 2014 | 1364 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9445 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3690 | 0.090 |
Why?
|
| Microtubules | 3 | 2012 | 1089 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 528 | 0.090 |
Why?
|
| Aging | 2 | 2015 | 8663 | 0.090 |
Why?
|
| Hemochromatosis | 1 | 2011 | 184 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2020 | 21747 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 452 | 0.090 |
Why?
|
| Ovalbumin | 2 | 2002 | 719 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 430 | 0.090 |
Why?
|
| Chaperonin 10 | 1 | 2009 | 18 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2020 | 1732 | 0.090 |
Why?
|
| Light | 4 | 2000 | 1374 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2013 | 675 | 0.090 |
Why?
|
| Larva | 1 | 2011 | 519 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2023 | 5390 | 0.090 |
Why?
|
| Egg Yolk | 1 | 2009 | 24 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2012 | 551 | 0.090 |
Why?
|
| Xenopus Proteins | 1 | 2012 | 433 | 0.090 |
Why?
|
| Internet | 3 | 2012 | 3064 | 0.090 |
Why?
|
| Host-Parasite Interactions | 1 | 2011 | 295 | 0.080 |
Why?
|
| Mitosis | 3 | 2013 | 1208 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3771 | 0.080 |
Why?
|
| Digestive System Diseases | 1 | 2010 | 147 | 0.080 |
Why?
|
| Secretin | 2 | 2021 | 57 | 0.080 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2009 | 105 | 0.080 |
Why?
|
| Monocytes | 2 | 2016 | 2596 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2011 | 291 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 270 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 2478 | 0.080 |
Why?
|
| Amino Acids | 5 | 2013 | 1737 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2012 | 868 | 0.080 |
Why?
|
| Ultrafiltration | 1 | 2008 | 57 | 0.080 |
Why?
|
| Iron Overload | 1 | 2010 | 242 | 0.080 |
Why?
|
| Antimitotic Agents | 1 | 2008 | 29 | 0.080 |
Why?
|
| Metabolomics | 3 | 2024 | 1485 | 0.080 |
Why?
|
| Cytokinesis | 1 | 2009 | 177 | 0.080 |
Why?
|
| Placenta | 1 | 2017 | 1699 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2019 | 3024 | 0.080 |
Why?
|
| Chromatin | 2 | 1992 | 2934 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 4251 | 0.080 |
Why?
|
| Body Patterning | 1 | 2012 | 626 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2001 | 6194 | 0.080 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 546 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 2918 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5263 | 0.070 |
Why?
|
| Quality Control | 2 | 2019 | 841 | 0.070 |
Why?
|
| Bisbenzimidazole | 1 | 1986 | 13 | 0.070 |
Why?
|
| Serotonin | 1 | 2011 | 1017 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2943 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1273 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2019 | 3309 | 0.070 |
Why?
|
| Base Sequence | 4 | 2012 | 12797 | 0.070 |
Why?
|
| Urologic Diseases | 1 | 2009 | 244 | 0.070 |
Why?
|
| Histones | 2 | 2015 | 2599 | 0.070 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 16692 | 0.070 |
Why?
|
| Head | 1 | 2012 | 880 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 1911 | 0.070 |
Why?
|
| Cell Cycle Proteins | 4 | 2013 | 3465 | 0.070 |
Why?
|
| Endosonography | 1 | 2010 | 610 | 0.070 |
Why?
|
| Plasmids | 1 | 2012 | 2308 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2011 | 1185 | 0.070 |
Why?
|
| Brain Stem | 1 | 2011 | 846 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 942 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1059 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2002 | 2184 | 0.070 |
Why?
|
| Terbium | 1 | 1985 | 8 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2012 | 1077 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 1073 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 18373 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2010 | 3524 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 1059 | 0.070 |
Why?
|
| Electron Transport | 1 | 2006 | 211 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2020 | 3749 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 361 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1061 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2408 | 0.060 |
Why?
|
| Chromosomes, Bacterial | 1 | 1986 | 282 | 0.060 |
Why?
|
| Asthma | 1 | 2024 | 6010 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2013 | 1350 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2011 | 634 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 2002 | 462 | 0.060 |
Why?
|
| DNA Replication | 2 | 1994 | 1399 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4479 | 0.060 |
Why?
|
| Fibrosis | 1 | 2011 | 2029 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5535 | 0.060 |
Why?
|
| Swine | 1 | 2014 | 5918 | 0.060 |
Why?
|
| HIV-1 | 1 | 2022 | 6939 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 814 | 0.060 |
Why?
|
| Fibronectins | 1 | 2008 | 726 | 0.060 |
Why?
|
| DNA Repair | 1 | 2013 | 2046 | 0.060 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 62 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1862 | 0.060 |
Why?
|
| Isotopes | 1 | 2024 | 124 | 0.060 |
Why?
|
| Factor VIII | 1 | 2006 | 347 | 0.060 |
Why?
|
| Transcription Factor TFIID | 1 | 2004 | 151 | 0.060 |
Why?
|
| Chemical Fractionation | 2 | 2015 | 65 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 498 | 0.060 |
Why?
|
| Cohort Studies | 9 | 2020 | 40558 | 0.060 |
Why?
|
| Time Factors | 7 | 2021 | 40077 | 0.060 |
Why?
|
| Nephrectomy | 2 | 2020 | 1050 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 2 | 2001 | 324 | 0.060 |
Why?
|
| Adult | 13 | 2017 | 214056 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 5868 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2009 | 1189 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1599 | 0.060 |
Why?
|
| Metabolome | 1 | 2010 | 895 | 0.060 |
Why?
|
| Leptin | 1 | 2011 | 1600 | 0.060 |
Why?
|
| Mollusk Venoms | 1 | 2002 | 19 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.060 |
Why?
|
| Conotoxins | 1 | 2002 | 20 | 0.060 |
Why?
|
| Mollusca | 1 | 2002 | 40 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 625 | 0.060 |
Why?
|
| Silver Staining | 1 | 2002 | 64 | 0.060 |
Why?
|
| Alkylation | 1 | 2002 | 86 | 0.050 |
Why?
|
| Protease Inhibitors | 2 | 2021 | 791 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 158 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2010 | 1547 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2866 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2002 | 131 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 669 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2002 | 136 | 0.050 |
Why?
|
| Binding Sites | 3 | 2010 | 6111 | 0.050 |
Why?
|
| Viral Fusion Proteins | 1 | 2022 | 96 | 0.050 |
Why?
|
| Endopeptidase K | 1 | 2001 | 23 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2011 | 2839 | 0.050 |
Why?
|
| Oxygen | 1 | 1994 | 4189 | 0.050 |
Why?
|
| Iron | 1 | 2010 | 1774 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1888 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10636 | 0.050 |
Why?
|
| Glycopeptides | 1 | 2003 | 226 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4208 | 0.050 |
Why?
|
| Anemia | 1 | 2011 | 1503 | 0.050 |
Why?
|
| Serine | 2 | 2020 | 826 | 0.050 |
Why?
|
| Calmodulin | 1 | 2002 | 209 | 0.050 |
Why?
|
| Solutions | 1 | 2002 | 426 | 0.050 |
Why?
|
| Disease Progression | 3 | 2024 | 13285 | 0.050 |
Why?
|
| Concanavalin A | 1 | 1981 | 191 | 0.050 |
Why?
|
| Urochordata | 1 | 2001 | 21 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 934 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10484 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 1120 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2002 | 166 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 1986 | 850 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2133 | 0.050 |
Why?
|
| Epidermal Growth Factor | 2 | 2001 | 709 | 0.050 |
Why?
|
| S Phase | 2 | 2013 | 423 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 4 | 2013 | 3848 | 0.050 |
Why?
|
| Zebrafish | 2 | 2014 | 2996 | 0.050 |
Why?
|
| Dieldrin | 1 | 2000 | 8 | 0.050 |
Why?
|
| Endoscopy | 1 | 2011 | 1787 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9240 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 8300 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2010 | 1332 | 0.050 |
Why?
|
| Methylation | 2 | 2015 | 1106 | 0.050 |
Why?
|
| Cord Factors | 1 | 2020 | 6 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2002 | 2556 | 0.050 |
Why?
|
| Nocodazole | 2 | 2008 | 97 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2011 | 2509 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 9735 | 0.050 |
Why?
|
| Protein Binding | 4 | 2020 | 9384 | 0.050 |
Why?
|
| Peptidomimetics | 1 | 2020 | 34 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 1352 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2005 | 452 | 0.050 |
Why?
|
| Neurotensin | 1 | 2000 | 61 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2012 | 12209 | 0.050 |
Why?
|
| Schizonts | 1 | 2020 | 22 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3037 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2012 | 2256 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2535 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3751 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3587 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2021 | 287 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2004 | 1899 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 5023 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2011 | 1678 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1992 | 3390 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 2013 | 311 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 4 | 2009 | 2700 | 0.040 |
Why?
|
| Protein Interaction Mapping | 3 | 2009 | 627 | 0.040 |
Why?
|
| Papua New Guinea | 1 | 2019 | 42 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 98 | 0.040 |
Why?
|
| Urea | 1 | 2001 | 450 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2012 | 5181 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2002 | 435 | 0.040 |
Why?
|
| Doxorubicin | 1 | 1985 | 2234 | 0.040 |
Why?
|
| RNA Stability | 1 | 2021 | 321 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 733 | 0.040 |
Why?
|
| Dogs | 2 | 2000 | 3912 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 1980 | 498 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 906 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1656 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 2001 | 1060 | 0.040 |
Why?
|
| Cell Wall | 1 | 2021 | 422 | 0.040 |
Why?
|
| DNA Damage | 2 | 2021 | 2432 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 553 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.040 |
Why?
|
| Antibodies | 2 | 2002 | 2460 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2017 | 98 | 0.040 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 72 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2021 | 772 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13695 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 6621 | 0.040 |
Why?
|
| Camptothecin | 1 | 2020 | 576 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63115 | 0.040 |
Why?
|
| Deuterium | 2 | 2010 | 101 | 0.040 |
Why?
|
| Young Adult | 3 | 2013 | 56434 | 0.040 |
Why?
|
| Genes, myc | 2 | 2000 | 399 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2000 | 982 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2017 | 167 | 0.040 |
Why?
|
| Alum Compounds | 1 | 2016 | 33 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2023 | 2227 | 0.030 |
Why?
|
| Middle Aged | 9 | 2013 | 213388 | 0.030 |
Why?
|
| Neuroepithelial Cells | 1 | 2015 | 22 | 0.030 |
Why?
|
| Lipid A | 1 | 2016 | 67 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 2736 | 0.030 |
Why?
|
| Spodoptera | 1 | 2016 | 153 | 0.030 |
Why?
|
| Culture Media | 2 | 2011 | 909 | 0.030 |
Why?
|
| Brain | 3 | 2018 | 26386 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2009 | 1683 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 428 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18034 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2015 | 70 | 0.030 |
Why?
|
| Poloxamer | 1 | 2015 | 57 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4666 | 0.030 |
Why?
|
| Affinity Labels | 2 | 2008 | 109 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2000 | 1254 | 0.030 |
Why?
|
| Sonication | 1 | 2015 | 83 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2014 | 21833 | 0.030 |
Why?
|
| Cell Death | 1 | 2000 | 1707 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2017 | 698 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 970 | 0.030 |
Why?
|
| Perphenazine | 1 | 2014 | 34 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1677 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Singlet Oxygen | 1 | 1994 | 53 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2015 | 246 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2017 | 1758 | 0.030 |
Why?
|
| Genomics | 2 | 2024 | 5717 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2019 | 41005 | 0.030 |
Why?
|
| Adolescent | 5 | 2022 | 85784 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 1994 | 84 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2015 | 743 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 1723 | 0.030 |
Why?
|
| Free Radicals | 1 | 1994 | 237 | 0.030 |
Why?
|
| Methylene Blue | 1 | 1994 | 155 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 1889 | 0.030 |
Why?
|
| Pigmentation | 1 | 2014 | 148 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 794 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2022 | 6387 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2013 | 39 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3300 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 2013 | 182 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 212 | 0.030 |
Why?
|
| Endocytosis | 2 | 2009 | 985 | 0.030 |
Why?
|
| Organizers, Embryonic | 1 | 2012 | 9 | 0.030 |
Why?
|
| Dopamine Antagonists | 1 | 2014 | 296 | 0.030 |
Why?
|
| Polymyositis | 1 | 2013 | 75 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 5882 | 0.030 |
Why?
|
| BRCA1 Protein | 2 | 2013 | 1149 | 0.030 |
Why?
|
| Genes, fos | 1 | 1992 | 183 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3505 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2008 | 959 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2017 | 1097 | 0.030 |
Why?
|
| Vacuoles | 1 | 2013 | 230 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 2007 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2013 | 4026 | 0.030 |
Why?
|
| Sumoylation | 1 | 2012 | 83 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2022 | 3420 | 0.030 |
Why?
|
| Introns | 1 | 2014 | 992 | 0.030 |
Why?
|
| Strongyloidiasis | 1 | 2011 | 27 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 2012 | 246 | 0.030 |
Why?
|
| DNA Probes | 1 | 1992 | 560 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 1179 | 0.030 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2011 | 12 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 494 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2027 | 0.020 |
Why?
|
| Histone Code | 1 | 2012 | 163 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 2647 | 0.020 |
Why?
|
| Abdomen, Acute | 1 | 2012 | 123 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 293 | 0.020 |
Why?
|
| Immune Sera | 1 | 2011 | 641 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 486 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3177 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2012 | 396 | 0.020 |
Why?
|
| Pregnancy | 3 | 2018 | 29144 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2016 | 4287 | 0.020 |
Why?
|
| Research | 1 | 2019 | 1999 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 281 | 0.020 |
Why?
|
| Colon | 1 | 2019 | 1772 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 3617 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 1813 | 0.020 |
Why?
|
| Dermatomyositis | 1 | 2013 | 224 | 0.020 |
Why?
|
| Genes, p53 | 1 | 1992 | 755 | 0.020 |
Why?
|
| Methods | 1 | 2010 | 1129 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1981 | 5524 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 1007 | 0.020 |
Why?
|
| Urothelium | 1 | 2012 | 277 | 0.020 |
Why?
|
| DNA, Helminth | 1 | 2009 | 34 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4805 | 0.020 |
Why?
|
| G1 Phase | 1 | 1991 | 415 | 0.020 |
Why?
|
| Vitellogenins | 1 | 2009 | 22 | 0.020 |
Why?
|
| Antibodies, Helminth | 1 | 2009 | 50 | 0.020 |
Why?
|
| India | 1 | 2016 | 2197 | 0.020 |
Why?
|
| Antigens, Helminth | 1 | 2009 | 64 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2013 | 752 | 0.020 |
Why?
|
| Rifampin | 2 | 1994 | 315 | 0.020 |
Why?
|
| Imidazoles | 1 | 2016 | 1206 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2015 | 1117 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Egg Proteins | 1 | 2009 | 58 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 440 | 0.020 |
Why?
|
| Interphase | 1 | 2009 | 226 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2009 | 103 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2000 | 3084 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2014 | 739 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 594 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2004 | 2050 | 0.020 |
Why?
|
| Palmitic Acid | 1 | 2009 | 154 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1549 | 0.020 |
Why?
|
| Prometaphase | 1 | 2008 | 6 | 0.020 |
Why?
|
| Autoantigens | 1 | 2013 | 892 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2015 | 2377 | 0.020 |
Why?
|
| Thiones | 1 | 2008 | 46 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2010 | 10252 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 464 | 0.020 |
Why?
|
| Radiation Effects | 1 | 1968 | 68 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 612 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15078 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2009 | 821 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1591 | 0.020 |
Why?
|
| Glucose | 1 | 2020 | 4398 | 0.020 |
Why?
|
| Plasma | 1 | 2011 | 575 | 0.020 |
Why?
|
| Energy Transfer | 1 | 1968 | 109 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
| Albumins | 1 | 2010 | 568 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2008 | 159 | 0.020 |
Why?
|
| Ferritins | 1 | 2010 | 590 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 895 | 0.020 |
Why?
|
| Liver | 3 | 2010 | 7475 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4185 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 937 | 0.020 |
Why?
|
| Ion Channels | 1 | 2012 | 1056 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2011 | 451 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2009 | 583 | 0.020 |
Why?
|
| Probability | 1 | 2013 | 2506 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 2126 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 643 | 0.020 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 310 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 13988 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 736 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6755 | 0.020 |
Why?
|
| Lasers | 1 | 1991 | 952 | 0.020 |
Why?
|
| Chloramphenicol | 1 | 1986 | 75 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1997 | 0.020 |
Why?
|
| Mitochondria | 1 | 2019 | 3514 | 0.020 |
Why?
|
| Phenotype | 1 | 2024 | 16367 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2011 | 9145 | 0.020 |
Why?
|
| Vincristine | 1 | 2008 | 1039 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 1968 | 405 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2009 | 459 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 1532 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1222 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 7722 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3873 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 2036 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5173 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2004 | 37 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 1807 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 1837 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 313 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2004 | 119 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2804 | 0.010 |
Why?
|
| Oocytes | 1 | 2009 | 1188 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1157 | 0.010 |
Why?
|
| Pedigree | 1 | 2012 | 4642 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 9857 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2011 | 3001 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2010 | 1431 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2916 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2012 | 2073 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2003 | 467 | 0.010 |
Why?
|
| Cell Movement | 1 | 2015 | 5218 | 0.010 |
Why?
|
| Chromatography | 1 | 2002 | 206 | 0.010 |
Why?
|
| Stem Cells | 1 | 2015 | 3567 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1986 | 1079 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2003 | 436 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 2505 | 0.010 |
Why?
|
| Intestines | 1 | 2011 | 1924 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2010 | 1809 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 1005 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4777 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1981 | 64 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 1714 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2004 | 705 | 0.010 |
Why?
|
| Thymidine | 1 | 1981 | 310 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2002 | 447 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7147 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 625 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1981 | 244 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2919 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2001 | 95 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2004 | 528 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1454 | 0.010 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2003 | 502 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3759 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2003 | 338 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2008 | 1708 | 0.010 |
Why?
|
| Leucine | 1 | 2002 | 560 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 1409 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2009 | 2504 | 0.010 |
Why?
|
| Glycosylation | 1 | 2003 | 1128 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 682 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 5749 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 2186 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 262 | 0.010 |
Why?
|
| Nitrates | 1 | 2001 | 265 | 0.010 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 144 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2000 | 919 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2000 | 334 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 2000 | 444 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11366 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2475 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 1154 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9312 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11525 | 0.010 |
Why?
|
| Growth Substances | 1 | 2000 | 784 | 0.010 |
Why?
|
| Kinetics | 1 | 1986 | 6476 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1247 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2001 | 881 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5101 | 0.010 |
Why?
|
| Veterans | 1 | 2011 | 2519 | 0.010 |
Why?
|
| Fluorescence | 1 | 1980 | 751 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4925 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11126 | 0.010 |
Why?
|
| Microspheres | 1 | 1980 | 777 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1981 | 1263 | 0.010 |
Why?
|
| Muscles | 1 | 2002 | 1614 | 0.010 |
Why?
|
| Cell Count | 1 | 1981 | 1856 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2012 | 53291 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1526 | 0.010 |
Why?
|
| Epithelium | 1 | 2001 | 1679 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 1643 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2011 | 6542 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2008 | 2943 | 0.010 |
Why?
|
| United States | 1 | 2024 | 69869 | 0.010 |
Why?
|
| Cell Separation | 1 | 1981 | 1751 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 15221 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1981 | 3144 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20823 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 4222 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5445 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1992 | 172 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15520 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15535 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1992 | 876 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 163284 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17445 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2001 | 3589 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1994 | 1465 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 10183 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1992 | 1797 | 0.000 |
Why?
|
| Cell Division | 1 | 1994 | 4569 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1992 | 806 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 72295 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1968 | 454 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29786 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35424 | 0.000 |
Why?
|
| Temperature | 1 | 1968 | 2204 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1992 | 2020 | 0.000 |
Why?
|